Terms: = Prostate cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Diagnosis
1846 results:
1. [prostate cancer - a disease in transformation].
Bratt O
Lakartidningen; 2024 Apr; 121():. PubMed ID: 38661575
[TBL] [Abstract] [Full Text] [Related]
2. Patterns of Care for Medicare Beneficiaries With Metastatic prostate cancer.
Filson CP; Richards TB; Ekwueme DU; Howard DH
Urol Pract; 2024 May; 11(3):489-497. PubMed ID: 38640419
[TBL] [Abstract] [Full Text] [Related]
3. [A single center study：An analysis of the safety and validity of delaying repeated biopsy for patients with atypical small acinar proliferation].
Ji WT; Liu DC; Cui WL; Hu Y; Wang Y; Tan JF
Zhonghua Nan Ke Xue; 2023 May; 29(5):414-419. PubMed ID: 38602757
[TBL] [Abstract] [Full Text] [Related]
4. Assessment of the accuracy of biparametric MRI/TRUS fusion-guided biopsy for index tumor evaluation using postoperative pathology specimens.
Shimizu R; Morizane S; Yamamoto A; Yamane H; Nishikawa R; Kimura Y; Yamaguchi N; Hikita K; Honda M; Takenaka A
BMC Urol; 2024 Apr; 24(1):79. PubMed ID: 38575912
[TBL] [Abstract] [Full Text] [Related]
5. prostate-Specific Antigen Screening in Smokers: A Comprehensive Analysis Using a National Behavioral Survey.
Harmatz IM; Alkhatib KY; Leff M; Nolazco JI; Michel KF; Slinger M; McLauchlan N; Cortese BD; Roberson DS; Schurhamer B; Lee DJ; Malkowicz SB; Trinh QD; Bivalacqua TJ; Guzzo TJ; Pierorazio PM
Urol Pract; 2024 May; 11(3):547-556. PubMed ID: 38564816
[TBL] [Abstract] [Full Text] [Related]
6. Combination of prostate volume and apparent diffusion coefficient can stratify patients with a PI-RADS score of 3 to reduce unnecessary prostate biopsies.
Dong Q; Wang C; Shen D; Ma Y; Zhang B; Xu S; Tao T; Xiao J
Prostate; 2024 Jun; 84(8):780-787. PubMed ID: 38558415
[TBL] [Abstract] [Full Text] [Related]
7. The treatment landscape of nonmetastatic castrate resistant prostate cancer: A contemporary perspective.
Yanada BA; Homewood D; Dias BH; Ogluszko C; Corcoran NM
Urol Oncol; 2024 Jun; 42(6):175.e9-175.e18. PubMed ID: 38555235
[TBL] [Abstract] [Full Text] [Related]
8. CD44 and CD133 protein expression might serve as a prognostic factor for early occurrence castration-resistant prostate cancer.
Dwina Y; Zaid LSM; Saraswati M; Rachmadi L; Kekalih A; Rahadiani N; Louisa M; Agustina H; Mochtar CA; Hamid ARAH
Prostate; 2024 Jun; 84(8):738-746. PubMed ID: 38528654
[TBL] [Abstract] [Full Text] [Related]
9. DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer.
Habeshian TS; Cannavale KL; Slezak JM; Shu YH; Chien GW; Chen X; Shi F; Siegmund KD; Van Den Eeden SK; Huang J; Chao CR
Epigenetics; 2024 Dec; 19(1):2308920. PubMed ID: 38525786
[TBL] [Abstract] [Full Text] [Related]
10. Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy.
Büttner T; Gärtner F; Essler M; Weiten R; Kristiansen G; Ellinger J; Ritter M; Krausewitz P
Prostate; 2024 Jun; 84(8):772-779. PubMed ID: 38504659
[TBL] [Abstract] [Full Text] [Related]
11. Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia Among Patients With Solid Tumors.
Hufnagel DH; Bos LM; Brown AJ; Prescott LS
J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38489926
[TBL] [Abstract] [Full Text] [Related]
12. Association between chronic prostatitis and the subsequent benign prostatic hyperplasia: a population-based national cohort study.
Lin TY; Chen IH; Weng HY; Lin YC; Ou CH; Li CY; Cheng YS
World J Urol; 2024 Mar; 42(1):126. PubMed ID: 38460003
[TBL] [Abstract] [Full Text] [Related]
13. Assessment of the Surgical Oncology Case Volume Within the Public Sector in Tanzania.
Brand NR; Akoko L; Kotecha V; Mwakyembe T; Mwashambwa M; Hamid R; Hando D; Komba C; Mwanga A; Mbele P; Itule P; Jackson J; Misidai M; Gaskill C; Ozgediz D
JCO Glob Oncol; 2024 Mar; 10():e2300316. PubMed ID: 38452305
[TBL] [Abstract] [Full Text] [Related]
14. Performance of standard systematic biopsy versus MRI/TRUS fusion biopsy using the Navigo® system in contemporary cohort.
Nativ O; Shefler A; Bejar J; Peschansky S; Lavi A; Michael C; Nativ O
Urol Oncol; 2024 May; 42(5):159.e1-159.e7. PubMed ID: 38431487
[TBL] [Abstract] [Full Text] [Related]
15. Sextant Systematic Biopsy Versus Extended 12-Core Systematic Biopsy in Combined Biopsy for prostate cancer.
Chung JH; Song W; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Park BK
J Korean Med Sci; 2024 Feb; 39(7):e63. PubMed ID: 38412610
[TBL] [Abstract] [Full Text] [Related]
16. Partial gland ablation with high intensity focal ultrasound impact on genito-urinary function and quality of life: our initial experience.
Fugaru I; Bouhadana D; Marcq G; Moryousef J; Rompré-Brodeur A; Meng A; Loutochin O; Loutochin G; Anidjar M; Bladou F; Sanchez-Salas R
Can J Urol; 2024 Feb; 31(1):11784-11792. PubMed ID: 38401258
[TBL] [Abstract] [Full Text] [Related]
17. Undiagnosed cancer Cases in the US During the First 10 Months of the COVID-19 Pandemic.
Burus T; Lei F; Huang B; Christian WJ; Hull PC; Ellis AR; Slavova S; Tucker TC; Lang Kuhs KA
JAMA Oncol; 2024 Apr; 10(4):500-507. PubMed ID: 38386344
[TBL] [Abstract] [Full Text] [Related]
18. Causes of death among people living with metastatic cancer.
Mani K; Deng D; Lin C; Wang M; Hsu ML; Zaorsky NG
Nat Commun; 2024 Feb; 15(1):1519. PubMed ID: 38374318
[TBL] [Abstract] [Full Text] [Related]
19. Genetic and epigenetic features of neuroendocrine prostate cancer and their emerging applications.
Zhang X; Barnett E; Smith J; Wilkinson E; Subramaniam RM; Zarrabi A; Rodger EJ; Chatterjee A
Int Rev Cell Mol Biol; 2024; 383():41-66. PubMed ID: 38359970
[TBL] [Abstract] [Full Text] [Related]
20. Bone marrow metastasis in nonhematological malignancies: A study from tertiary care center.
Singh A; Rawat S; Kushwaha R; Jain M; Verma SP; Verma N; Singh US
Ann Afr Med; 2024; 23(1):91-99. PubMed ID: 38358178
[TBL] [Abstract] [Full Text] [Related]
[Next]
